Results 161 to 170 of about 3,318,148 (301)

Psychological aspects of disaster

open access: yes, 1990
5.00Available from British Library Document Supply Centre- DSC:q91/08978(Psychological) / BLDSC - British Library Document Supply CentreSIGLEGBUnited ...
British Psychological Society, Leicester (United Kingdom)
core  

Anodal Transcranial Direct Current Stimulation Improves Social Behavior Alongside Neuroplastic Changes in a Tsc2+/− Rat Model of Autism Spectrum Disorder

open access: yesAutism Research, EarlyView.
ABSTRACT Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by altered synaptic connectivity and network organization, resulting in profound impairments in social communication and interaction. Transcranial direct current stimulation (tDCS) represents a promising approach to modulate maladaptive plasticity associated with ASD;
Antonia Ramme   +9 more
wiley   +1 more source

VISHADA: AN AYURVEDIC PERSPECTIVE ON PSYCHOLOGICAL INHIBITION

open access: yes
Vishada is an Ayurvedic concept describing a state of mental disturbance in which emotional strength, confidence, initiative, and engagement with daily life becomes diminished. It extends beyond temporary sadness and involves changes in mental, behavioural and physical functioning.
openaire   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk   +5 more
wiley   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove   +4 more
wiley   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher   +7 more
wiley   +1 more source

Can ultrasound guide treatment decisions in difficult‐to‐treat rheumatoid arthritis?

open access: yes
Arthritis &Rheumatology, Accepted Article.
Danila Madonna   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy